

Researchers screened 774 FDA-approved drugs using zebrafish to create a precision medicine map for autism, identifying levocarnitine as a compound that reverses brain deficits caused by specific genetic mutations.

The breakthrough could help doctors match treatments to individual patients based on their unique genetic profile.

Want to know more?